November 30th 2023
Federal guidance from the United States Pharmacopeia characterizes the practice as drug compounding, which pharmacists fear may drive up prices.
November 28th 2023
Maintaining the structure and function of antibody biologics like faricimab is critical for their administration via intravitreal injection (IVI), a common treatment approach for retinal diseases.
November 17th 2023
Zonisamide has a role in the treatment of epilepsy and is being explored in other central nervous system disorders.
November 15th 2023
Compounding parenteral nutrition solutions is a complex process with a high risk for error, which can lead to serious adverse outcomes.
November 10th 2023
A study found that the average difference between the pilocarpine HCL solution and Pilogel discs was -3.25 mmol/L and 0.69 mmol/L.
Pharmacy Compounders Defend Semaglutide Compounding Amid Continued Shortages
Novo Nordisk is the only company with FDA-approved products containing semaglutide.
USP <797> Updated Guidelines
The long-awaited revised USP <797> guidelines will become official on November 1, 2023.
FDA: Updated Guidance to Increase Ibuprofen Supply for Children
The FDA has updated its compounding guidelines for licensed pharmacies, hospitals, and health systems.
2 Clarke Drive Cranbury, NJ 08512